Downloadable Materials

These materials are intended to help you understand more about cystic fibrosis (CF) and treatment with KALYDECO® (ivacaftor).

For Healthcare Professionals: Delivering KALYDECO to Patients as Young as 6 Months1 

Download this brochure for an overview of clinical trial data in patients with CF age 6 months and older with ivacaftor-responsive CFTR mutations

For Your Patients: A Guide to KALYDECO for Patients and Caregivers

Download this brochure for a summary of who KALYDECO is for, how it works, how it was studied, and how it's taken